Exact Mass: 368.1987
Exact Mass Matches: 368.1987
Found 500 metabolites which its exact mass value is equals to given mass value 368.1987
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hirsutine
Annotation level-1 Hirsutine is a natural product found in Uncaria tomentosa, Mitragyna hirsuta, and other organisms with data available. See also: Cats Claw (part of).
Methoxyfenozide
CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9207; ORIGINAL_PRECURSOR_SCAN_NO 9204 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4782; ORIGINAL_PRECURSOR_SCAN_NO 4777 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4744; ORIGINAL_PRECURSOR_SCAN_NO 4743 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9204; ORIGINAL_PRECURSOR_SCAN_NO 9202 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9198; ORIGINAL_PRECURSOR_SCAN_NO 9195 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4851; ORIGINAL_PRECURSOR_SCAN_NO 4847 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4749; ORIGINAL_PRECURSOR_SCAN_NO 4745 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4763; ORIGINAL_PRECURSOR_SCAN_NO 4760 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9185; ORIGINAL_PRECURSOR_SCAN_NO 9184 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4756; ORIGINAL_PRECURSOR_SCAN_NO 4754 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9149; ORIGINAL_PRECURSOR_SCAN_NO 9146 CONFIDENCE standard compound; INTERNAL_ID 278; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9175; ORIGINAL_PRECURSOR_SCAN_NO 9172 D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
FT-0775149
LysoPA(a-13:0/0:0)
LysoPA(a-13:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(a-13:0/0:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(i-13:0/0:0)
LysoPA(i-13:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-13:0/0:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
(2-((3,5-Di-t-butyl-4-hydroxyphenyl)thio)-1-methylpropoxy)acetic acid
Methyl (1S,17R)-17-(2-methoxyethyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
1-Naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
Arginyl-prolyl-proline
Corynantheidine
N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine
Modecainide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Pentamorphone
Voacangine
(-)-voacangine is a monoterpenoid indole alkaloid with formula C22H28N2O3, isolated from several plant species. It has a role as an angiogenesis inhibitor, an antineoplastic agent and a plant metabolite. It is a monoterpenoid indole alkaloid, a tertiary amino compound, a methyl ester, an organic heteropentacyclic compound and an alkaloid ester. It is a conjugate base of a (-)-voacangine(1+). Voacangine is a natural product found in Voacanga thouarsii, Voacanga schweinfurthii, and other organisms with data available. A monoterpenoid indole alkaloid with formula C22H28N2O3, isolated from several plant species.
dihydrocorynantheine
A natural product found in Uncaria macrophylla.
(2S,3S,4S,8R,9S,13R,14R,15S,16R)-3,4,8,14,15-pentahydroxy-2,13,16-trimethyl-6-methylidene-10-oxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadecan-11-one
phthalic acid mono-[2-methyl-5-(2-methyl-3-methylene-[2]norbornyl)-pent-2-enyl ester]|Phthalsaeure-mono-[2-methyl-5-(2-methyl-3-methylen-[2]norbornyl)-pent-2-enylester]
(19R)-1-acetyl-17,19-epoxy-3-methoxy-curane|N(a)-acetyl-O-methylstrychnosplendine|N-acetyl-O-methyl-strychnosplendine|N-Acetyl-O-methylstrychnosplendin|O-Methyl-N-acetyl-strychnosplendin|O-Methyl-Na-acetylstrychnosplendine
2-(4-Methoxyphenyl)-5,7-dimethoxy-6-(3-methyl-2-butenyl)-3,4-dihydro-2H-1-benzopyran
3alpha-isobutyryloxy-5beta-(4-hydroxytigloyloxy)-7-hydroxycarvotacetone|3alpha-isobutyryloxy-5beta-<4-hydroxytigloyloxy>-7-hydroxycarvotacetone
(19R)-1-Acetyl-17,19-epoxy-11-methoxy-curan|(19R)-1-acetyl-17,19-epoxy-11-methoxy-curane|Strychnosperimin|Strychnospermin|Strychnospermine
2,3-epoxy-5beta,6cbeta;,10alpha,13beta,16alpha-pentahydroxy-grayanane|craiobiotoxin IX
(6E)-1-(2,4-dihydroxyphenyl)-3,7-dimethyl-3-vinyl-8-(4-methyl-2-furyl)-6-octen-1-one|1-(2,4-dihydroxyphenyl)-3,7-dimethyl-3-vinyl-8-(4-methyl-2-furyl)-6(E)-octen-1-one
Rhodojaponin III
Rhodojaponin III is a diterpenoid from the leaves of Rhododendron molle with anti-inflammatory activity[1]. Rhodojaponin III is a diterpenoid from the leaves of Rhododendron molle with anti-inflammatory activity[1].
1beta,3alpha-diethyloxy-7-hydroxymethyl-4-(3-methyl-butyryloxymethyl)-cyclopenta-4(4a),7(7a)-diene[c]pyran-6-one
rhodomollein F,,2,3,6,14,16-pentahydroxyl-5,9-epoxy grayanotoxane
(4E,7E)-1-(2,4-dihydroxyphenyl)-9-(4-methylfuran-2-yl)-3,4,8-trimethylnona-4,7-dien-1-one|ferulaeone D
3-hydroxymethyl-aspidofractinine-3-carboxylic acid methyl ester|Kopsinolin
1-formyl-16,17-dimethoxy-aspidofractinine|N-Formyl-16,17-dimethoxy-aspidofractinin
(4S,4aS,5R,6S,8aS,9aS)-6-(acetyloxy)-4a,5,6,7,8,8a,9,9a-octahydro-8a-hydroxy-4,9a-dimethoxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one|3beta-acetoxy-10beta-hydroxy-6beta,8beta-dimethoxyeremophil-7(11)-en-12,8alpha-olide
(5S,6E,8Z,11Z,13E,15S)-5,15-Dihydroperoxy-6,8,11,13-eicosatetraenoic acid
(S)-3-((Z)-4-Geranyloxy-benzyliden)-6-methyl-piperazin-2,5-dion|(S)-3-((Z)-4-geranyloxy-benzylidene)-6-methyl-piperazine-2,5-dione|deoxymycelianamide
13a,3a-(Epoxyethano)-1H-indolizino[8,1-cd]carbazole, 6-acetyl-2,3,4,5,5a,6,11,12-octahydro-7-methoxy-
1-hydroxy-6,6,9-trimethyl-3-pentyl-6H-benzo[c]chromene-2-carboxylic acid methyl ester|Cannabinolinsaeure-methylester|Cannabinolsaeure-methylester
17-phenyl trinor Prostaglandin A2
Methoxyfenozide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 2935 EAWAG_UCHEM_ID 2935; CONFIDENCE standard compound
C20H32O6_(2E)-2-(1,2-Dihydroxyethyl)-4-[(1R,4aS,5R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]-2-butenoic acid
C19H28O7_4H-Phenanthro[10,1-bc]furan-4-one, tetradecahydro-1,2,6,9,10-pentahydroxy-3,10a,10c-trimethyl-7-methylene-, (1S,2R,3R,5aS,6R,9S,10S,10aS,10cR)
(S,E)-2-(4,8-dimethylnona-3,7-dien-1-yl)-5-hydroxy-2-methyl-2H-chromene-7,8-dicarbaldehyde
Thromboxane B3
A member of the class of thromboxanes B that is (5Z,13E,17Z)-thromboxa-5,13,17-trien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0072.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001323.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001323.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001323.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001323.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001323.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0072.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0072.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001323.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ]
(2S,3S,4S,8R,9S,13R,14R,15S,16R)-3,4,8,14,15-pentahydroxy-2,13,16-trimethyl-6-methylidene-10-oxatetracyclo[7.6.1.0²,?.0¹²,¹?]hexadecan-11-one
Ala Ala Ala His
Ala Ala His Ala
Ala His Ala Ala
Gly Gly His Val
Gly Gly Val His
Gly His Gly Val
Gly His Val Gly
Gly Pro Pro Val
Gly Pro Val Pro
Gly Val Gly His
Gly Val His Gly
Gly Val Pro Pro
His Ala Ala Ala
His Gly Gly Val
His Gly Val Gly
His Val Gly Gly
Pro Gly Pro Val
Pro Gly Val Pro
Pro Pro Gly Val
Pro Pro Val Gly
Pro Val Gly Pro
Pro Val Pro Gly
Val Gly Gly His
Val Gly His Gly
Val Gly Pro Pro
Val His Gly Gly
Val Pro Gly Pro
Val Pro Pro Gly
5,12-dihydroperoxy-6,8,10,14-eicosatetraenoic acid
5,15-dihydroperoxy-6,8,11,13-eicosatetraenoic acid
8,15-dihydroperoxy-5,9,11,13-eicosatetraenoic acid
6,15-Diketo-13,14-dihydro-PGF1a
20-hydroxy-PGE2
Eganoprost
5,15-diHPETE
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
8,15-diHPETE
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
Longilactone, delta-4(18)-Isomer, 2alpha-alcoho
Prostaglandin G2
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
FA 20:4;O4
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
trans,trans-3,4,5-trifluorophenyl 4-ethylbicyclohexyl-4-carboxylate
2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride
N-[5-(1,1-dimethylethyl)-2-ethoxyphenyl]-N-(2-ethylphenyl)oxamide
BMS-690514
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
tert-Butyl 5-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
tert-Butyl 6-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
4,4,4,4,7,7-hexamethyl-2,2-spirobi[3H-chromene]-6,6-diol
2-[(1E,3E,5E)-6-(DIMETHYLAMINO)HEXA-1,3,5-TRIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM TETRAFLUOROBORATE
2-[2-(4-hydroxyphenyl)ethyl]-5-methoxy-4-(pentylamino)-3H-isoindol-1-one
4,4-Dihydroxy-3,3,5,5-tetramethyldiphenylmethane diglycidyl ether
4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, hydrogen sulfate, sodium salt
2-Hydroxy-2-methyl-1-phenyl-1-propanone mixt. with (1-hydroxycyclohexyl)phenylmethanone
METHYL 2-(BENZYLOXY)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
18-Methoxycoronaridine
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist
4-Amino-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol
20-Hydroxylipoxin B4
A member of the class of lipoxins that is lipoxin B4 carrying an additional hydroxy substituent at position 20.
[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl](4,5,6,7-tetrahydro-2H-indazol-3-yl)methanone
Modecainide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
3,4,8,14,15-Pentahydroxy-2,13,16-trimethyl-6-methylidene-10-oxatetracyclo[7.6.1.02,7.012,16]hexadecan-11-one
(5Z,13E,15S)-11alpha,15,19-trihydroxy-6,9alpha-epoxyprosta-5,13-dien-1-oic acid
(2-((3,5-Di-t-butyl-4-hydroxyphenyl)thio)-1-methylpropoxy)acetic acid
[(9R,10S,12S,13S,14R,16S,18R)-13-ethyl-14-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-yl] acetate
methyl (1R,10R,12R,19S)-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
20-hydroxylipoxin A4
A member of the class of lipoxins that is lipoxin A4 carrying an additional hydroxy substituent at position 20.
11-Dehydro-thromboxane B2
A thromboxane obtained by formal oxidation of the hemiacetal hydroxy function of thromboxane B2.
(E)-7-[6-[(E)-3,7-dihydroxyoct-1-enyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid
[3-carboxy-2-[(6E,8E,10E)-11-carboxyundeca-6,8,10-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,7E,10E)-11-carboxyundeca-4,7,10-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(2E,6E,8E)-11-carboxyundeca-2,6,8-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(5E,7E,9E)-11-carboxyundeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,6E,8E)-11-carboxyundeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(3E,6E,9E)-11-carboxyundeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium
19-Hydroxyprostaglandin H2
A prostaglandin H that consists of prostaglandin H2 bearing an additional hydroxy substituent at position 19.
1-butyl-5-[1-[2-(1H-indol-3-yl)ethylamino]ethylidene]-1,3-diazinane-2,4,6-trione
(E)-4-[(1R,4aS,5R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-2-(1,2-dihydroxyethyl)but-2-enoic acid
Pro-Val-Gly-Pro
A tetrapeptide composed of L-proline, L-valine, glycine, and L-proline joined by peptide linkages.
4-[cyclohexyl(methyl)amino]-N-(6-methyl-2-pyridinyl)-3-nitrobenzamide
4-[(E)-{2-[2,6-di(pyrrolidin-1-yl)pyrimidin-4-yl]hydrazinylidene}methyl]benzene-1,2-diol
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(Z)-N-[4-(9H-Fluoren-9-yl)piperazin-1-yl]-1-pyridin-4-ylethanimine
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-(1-oxopropyl)-1,4-diazabicyclo[4.2.0]octan-2-one
[(1R,9R,10S,12R,13S,14R,16S)-13-ethyl-14-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-yl] acetate
(5Z,13E,15S)-9alpha,11alpha-epoxy-15,18-dihydroxythromboxa-5,13-dien-1-oic acid
(5Z,13E,15S)-9alpha,11alpha-epoxy-15,19-dihydroxythromboxa-5,13-dien-1-oic acid
(5S,6Z,8E,10E,12R,14Z)-5,12,20,20-tetrahydroxyicosa-6,8,10,14-tetraenoic acid
(5Z,8Z,10E,12E,14R,15S)-14,15-bis(hydroperoxy)icosa-5,8,10,12-tetraenoic acid
(5S,6R,7E,9E,11Z,13E,15S)-15-hydroperoxy-5,6-dihydroxyicosa-7,9,11,13-tetraenoic acid
(9R,17R)-9-fluoro-6,11,16,17-tetrahydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(1S,5R)-7-[4-[(Z)-2-phenylethenyl]phenyl]-6-(pyrimidin-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptane
6-[4-(1-cyclohexyl-2H-tetrazol-1-ium-5-yl)butoxy]-1H-quinolin-2-one
(2-Acetamido-3-hydroxyoctyl) 2-(trimethylazaniumyl)ethyl phosphate
(2S,3S,4S,8R,9S,13R,14R,15S,16R)-3,4,8,14,15-pentahydroxy-2,13,16-trimethyl-6-methylidene-10-oxatetracyclo[7.6.1.0(2),.0(1)(2),(1)]hexadecan-11-one
6-Oxoprostaglandin e1
A prostaglandin E that is prostaglandin E1 bearing a keto substituent at the 6-position. D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(1R,2S,4S,6R,10S,11S,13S,14S)-11-(1-hydroxypropan-2-yl)-3,7,10-trimethyl-15-oxapentacyclo[7.5.1.02,6.07,13.010,14]pentadecane-4,6,9,14-tetrol
(1R,2R,3S,6R,10S,11S,13S,14S)-11-(1-Hydroxypropan-2-yl)-3,7,10-trimethyl-15-oxapentacyclo[7.5.1.02,6.07,13.010,14]pentadecane-3,6,9,14-tetrol
CB13
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
6,15-diketo,13,14-dihydroprostaglandin F1alpha
A prostaglandin Falpha that is prostaglandin F1alpha bearing keto substituents at positions 6 and 15.
8(S),15(S)-DiHPETE
An icosanoid that is (5Z,9E,11Z,13E)-icosatetraenoic acid carrying two hydroperoxy substituents at positions 8 and 15 (the 8S,15S-stereoisomer).
Methyl 2-(3-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
(5S,15S)-dihydroperoxy-(6E,8Z,11Z,13E)-icosatetraenoic acid
A bis(hydroperoxy)icosatetraenoic acid that is (6E,8Z,11Z,13E)-icosatetraenoic acid in which the two hydroperoxy groups are located at positions 5S and 15S.
14(R),15(S)-DiHPETE
A bis(hydroperoxy)icosatetraenoic acid that is (5Z,8Z,10E,12E)-icosatetraenoic acid carrying two hydroperoxy substituents at positions 14 and 15 (the 14R,15S-stereoisomer).
(5S,6R)-dihydroxy-(15S)-hydroperoxy-(7E,9E,11Z,13E)-icosatetraenoic acid
A hydroperoxy(hydroxy)icosatetraenoic acid that is (7E,9E,11Z,13E)-icosatetraenoic acid carrying 2 hydroxy substituents at positions 5S and 6R as well as a hydroperoxy substituent at position 15S.
19-hydroxyprostaglandin I2
A prostaglandin I that consists of prostaglandin I1 carrying an additional hydroxy substituent at position 19.
19-hydroxythromboxane A2
A thromboxane A that is thromboxane A2 carrying an additional hydroxy substituent at position 19.
18-hydroxythromboxane A2
A thromboxane A that is thromboxane A2 carrying an additional hydroxy substituent at position 18.
(2r,3r)-3-chloro-3,7,11-trimethyl-1-(5-nitro-1h-pyrrol-3-yl)dodeca-6,10-dien-2-ol
(1s,3r,4r,6r,7s,8r,10s,13r,14r,16r)-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,14,16-hexol
(1s,3r,4r,8s,9r,10r,13r,14r,16r)-3,4,9,14,16-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-6-one
(9s,10r,13r,14s,21r)-8-acetyl-13,16-dimethyl-12-oxa-8,16-diazapentacyclo[8.8.3.0¹,⁹.0²,⁷.0¹⁴,²¹]henicosa-2,4,6-trien-19-one
4-(acetyloxy)-5-hydroxy-5-undecanoylcyclopent-2-en-1-yl acetate
(1r,2s,4s,4as,5s,5'r,5''s,8as)-4,5''-dihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydrodispiro[naphthalene-1,2':5',3''-bis(oxolane)]-3-one
1,12-dihydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradecan-9-yl 2-methylpropanoate
(1s,3s,4r,6r,7s,8r,10s,13r,14r,16r)-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,14,16-hexol
(1r,4r,6s,8r,9s,10s,11s)-10-(acetyloxy)-6-formyl-9-isopropyl-1-methyl-5,12-dioxatricyclo[9.1.0.0⁴,⁶]dodecan-8-yl acetate
[(1r,3r)-1,3-diethoxy-7-(hydroxymethyl)-6-oxo-1h,3h,5h-cyclopenta[c]pyran-4-yl]methyl 3-methylbutanoate
(1r,2s,3s,5s,6r,7r,8s,9r,10s,11r,18r)-6,12,12-trimethyl-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol
1,13-dihydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradecan-9-yl 2-methylpropanoate
4-methoxy-6-(2,4,8-trihydroxy-3,7,9-trimethylundeca-5,9-dien-1-yl)-5,6-dihydropyran-2-one
(1r,9r,10s,12r,13s,14r,16s,17s,18r)-13-ethyl-14-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-yl acetate
(3r,4r,8s,9r,10r,14r,16s)-3,4,9,14,16-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-6-one
(1r,4s,6s,10r,13s,14r,17s)-10-hydroperoxy-13-hydroxy-4,13,17-trimethyl-9-methylidene-5,15-dioxatricyclo[12.3.1.0⁴,⁶]octadecan-16-one
(1r,2s,4s,9r,10r)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl benzoate
(1r,3r,4r,6r,7r,8s,9r,10r,13s,16r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,16-hexol
4-{[(1s,4r,6r,7r,8r,9r,13s)-6,9-dihydroxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-7-yl]oxy}-4-oxobutanoic acid
(1r,3s,4r,7s,11s,12r)-3,4,7,11-tetrahydroxy-4,12-dimethyl-8,15-dimethylidene-13-oxabicyclo[10.3.2]heptadecan-14-one
(1r,2r,3r,4as,5s,5'r,5''r,8as)-3,5''-dihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydrodispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-one
(1s,3s,4r,6s,7s,8s,10s,13r,14s,16r)-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,14,16-hexol
(1r,4s,6s,10s,13s,14r,17s)-10-hydroperoxy-13-hydroxy-4,13,17-trimethyl-9-methylidene-5,15-dioxatricyclo[12.3.1.0⁴,⁶]octadecan-16-one
1-[(1s,12s,13r,17s,18r)-6-methoxy-3,20-dimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl]ethanone
11-isopropyl-3,7,10-trimethyl-15-oxapentacyclo[7.5.1.0²,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecane-6,9,11,13,14-pentol
2-[5-(carboxymethyl)-2,5,8a-trimethyl-2-(oxiran-2-yl)-hexahydro-1-benzopyran-6-yl]-2-methylpropanoic acid
(1r,2s,4s,4as,5s,5'r,5''r,8as)-4,5''-dihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydrodispiro[naphthalene-1,2':5',3''-bis(oxolane)]-3-one
(3as,4s,6s,10r,11s,11ar)-4,10-dihydroxy-6,10-dimethyl-3-methylidene-2,5-dioxo-octahydrocyclodeca[b]furan-11-yl 2-methylpropanoate
n-{2-[6-(3,4-dimethoxyphenyl)-7,8-dihydro-5h-quinolin-6-yl]ethyl}-n-methylacetamide
(1r,2r,3r,4as,5s,5'r,5''s,8as)-3,5''-dihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydrodispiro[naphthalene-1,2':5',3''-bis(oxolane)]-4-one
(1r,2r,3s,4s,5s,9s,10s,13r,14s)-2,3,14-trihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
4-{[(1s,4r,5r,6r,7r,8r,9r,13s)-6,9-dihydroxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-7-yl]oxy}-4-oxobutanoic acid
(1r,3r,4r,6s,7r,8r,9s,10s,13s,16r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,6,7,9,16-hexol
methyl (1s,15r,17s,18s)-17-ethyl-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
methyl (13e)-13-ethylidene-4-methoxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate
(5z)-7-[(1s,4r,5r,6r)-6-[(1e,3s)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid
(2s)-2,5,7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-1-benzopyran
{6-hydroxy-7-methyl-1-[(3-methylbutanoyl)oxy]-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-yl}methyl 3-methylbutanoate
10-methoxycathafoline
{"Ingredient_id": "HBIN000165","Ingredient_name": "10-methoxycathafoline","Alias": "NA","Ingredient_formula": "C22H28N2O3","Ingredient_Smile": "CC=C1CN2CCC34C(C1CC2C3N(C5=C4C=C(C=C5)OC)C)C(=O)OC","Ingredient_weight": "368.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13871","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "71719400","DrugBank_id": "NA"}
15-epi-leopersin o
{"Ingredient_id": "HBIN001675","Ingredient_name": "15-epi-leopersin o","Alias": "NA","Ingredient_formula": "C20H32O6","Ingredient_Smile": "CC1C(C(=O)C2C(CCCC2(C13CCC4(O3)CC(OC4)O)C)(C)CO)O","Ingredient_weight": "368.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6948","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15834304","DrugBank_id": "NA"}
15-epi-leopersin q
{"Ingredient_id": "HBIN001676","Ingredient_name": "15-epi-leopersin q","Alias": "NA","Ingredient_formula": "C20H32O6","Ingredient_Smile": "CC1C(=O)C(C2C(CCCC2(C13CCC4(O3)CC(OC4)O)C)(C)CO)O","Ingredient_weight": "368.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6949","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15834667","DrugBank_id": "NA"}
2α-hydroxytirotundin
{"Ingredient_id": "HBIN005297","Ingredient_name": "2\u03b1-hydroxytirotundin","Alias": "NA","Ingredient_formula": "C19H28O7","Ingredient_Smile": "CC1CC2C(C(CC3(CC(C1(O3)O)O)C)OC(=O)C(C)C)C(=C)C(=O)O2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10768","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
adenostemmoic acid c
{"Ingredient_id": "HBIN014705","Ingredient_name": "adenostemmoic acid c","Alias": "NA","Ingredient_formula": "C20H32O6","Ingredient_Smile": "CC12CCCC(C1CCC34C2C(CC(C3)C(C4O)(CO)O)O)(C)C(=O)O","Ingredient_weight": "368.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "24816","TCMSP_id": "NA","TCM_ID_id": "7152","PubChem_id": "23260137","DrugBank_id": "NA"}